Press Releases

Triphase Accelerator and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced interim results for Triphase Accelerator’s multi-center, open-label, monotherapy study of TRPH-222...

In an in-depth review of the market and having evaluated the collective developments from this year’s Pharmapack event, Gregor Anderson – MD of Pharmacentric Solutions – offers a positive appraisal of pharma’s drive towards sustainability. “I am really encouraged by...

Thermo Fisher Scientific Inc., the world leader in serving science, announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of...

Roche announced that the US FDA has approved Tecentriq as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or PD-L1...

Duke-NUS Medical School (Duke-NUS), a research intensive graduate-entry medical school, GenScript Biotech Corporation, a leading global biotechnology company, and the Diagnostics Development Hub (DxD) at Singapore's Agency for Science, Technology and Research (A*STAR), announced an exclusive agreement to co-develop...

WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced the expansion of its service capabilities to offer a fully integrated Closed Process CAR-T Cell Therapy Platform....

Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has acquired a pharmaceutical packaging facility from Quality Packaging Specialists International, LLC (QPSI). The site, located in Macungie, Pennsylvania, will offer primary and secondary...